Impact BioMedical Investor Relations Material
Latest events
Q2 2025
14 Aug, 2025
Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Impact BioMedical Inc
Access all reports
Impact BioMedical Inc is a U.S.-based life sciences company engaged in the research, development, and commercialization of biomedical solutions. The company focuses on developing innovative products across various areas, including antiviral and antimicrobial treatments, regenerative medicine, and wellness applications. Impact BioMedical utilizes advanced scientific platforms to address global health challenges and collaborates with research institutions and industry partners to bring its technologies to market. The company is headquartered in Jacksonville, Florida, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
IBO
Country
🇺🇸 United States